It is clear the success of an efficacious, patient-centric precision medicine fundamentally rests on a solid predictive biomarker foundation. This importance only heightens as multiple drug developers fight for market share for similar targets in similar indications and healthcare providers and payers demand to see more robust clinical benefit to specific patient cohorts.
Built for biomarker, translational and clinical experts, the Clinical Biomarkers stream will help you overcome challenges in the discovery, development and clinical validation of novel biomarkers. From addressing heterogeneity of disease to exploratory biomarker endeavours, validation of patient stratifying predictive signatures and the latest assaying technology, the Clinical Biomarkers stream will showcase the demonstration of biomarker clinical utility to accelerate the approval of next generation precision medicines.
Key Topics to be Addressed in 2019: